U.S. markets closed

MYM Nutraceuticals Inc. (MYM.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.1200-0.0100 (-7.69%)
At close: 2:51PM EDT
Full screen
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.1300
Bid0.1200 x 0
Ask0.1300 x 0
Day's Range0.1200 - 0.1300
52 Week Range0.0450 - 0.2400
Avg. Volume417,628
Market Cap29.995M
Beta (5Y Monthly)0.92
PE Ratio (TTM)N/A
EPS (TTM)-0.0130
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • Newsfile

      MYM Provides Timeline for Special Meeting of Shareholders and Announces Exchange of Special Shares

      Vancouver, British Columbia--(Newsfile Corp. - May 25, 2021) - MYM Nutraceuticals Inc. (CSE: MYM) (OTCQB: MYMMF) ("MYM" or the "Company") published a notice of meeting and record date for the upcoming special meeting of shareholders of MYM (the "Meeting") disclosing that the record date will be May 31, 2021 and the Meeting will be on July 5, 2021. At the Meeting, shareholders will be asked to consider and vote on a special resolution approving, among ...

    • Newsfile

      Acquisition of Shares by Cultivator Catalyst Corp.

      Toronto, Ontario--(Newsfile Corp. - May 21, 2021) - MYM Nutraceuticals Inc. (CSE: MYM) ("MYM" or the "Company"): This press release is being disseminated by Cultivator Catalyst Corp. (the "Acquiror") as required by National Instrument 62-103 The Early Warning System and Related Take-Over Bids and Insider Reporting Issues in connection with its acquisition of securities of MYM.Effective May 21, 2021, the Acquiror acquired 88,904,428 Common Shares in the capital of the Company, pursuant to a ...

    • MYM Releases Q3 2021 Financial Results

      MYM Releases Q3 2021 Financial Results

      Vancouver, British Columbia--(Newsfile Corp. - April 30, 2021) - MYM Nutraceuticals Inc., (CSE: MYM) (OTCQB: MYMMF) ("MYM" or the "Company") today announced its financial results for the three-month period ending February 28, 2021 ("Q3 2021"). The Company's Financial Statements and Management Discussion & Analysis ("MD&A") are available on sedar.com. Key Highlights for Q3 2021Gross revenue of $4.4 million, an increase of 8% from the prior quarterPositive EBITDA of $212,628Expanded distribution to three new ...